Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nutrivert
AddedFeb 17, 2024
UpdatedJun 18, 2026
Nutrivert

Nutrivert

Seed

Nutrivert offers postbiotics as an alternative to antibiotics, enhancing livestock feed efficiency.

HQ
Atlanta, GA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Nutrivert, founded with the mission to revolutionize livestock production, focuses on providing alternatives to traditional antibiotics. The company offers postbiotics, which are specially formulated feed additives designed to enhance livestock feed conversion efficiency. This innovative approach aims to address the growing concerns over antibiotic use in animal husbandry, benefiting both producers and consumers by promoting healthier livestock and more sustainable farming practices.

Nutrivert has garnered attention from notable investors and industry experts who recognize the potential impact of reducing antibiotic dependency in livestock. The company's achievements include developing a proprietary postbiotic formulation that has shown promising results in improving feed efficiency. By offering a viable alternative to antibiotics, Nutrivert is contributing to a significant shift in the agricultural industry, promoting better animal health and more sustainable food production practices.

Nutrivert - Similar Companies

Pando Nutrition logo

Pando Nutrition

pandonutrition.com

NovoNutrients logo

NovoNutrients

novonutrients.com

Advanced Bionutrition logo

Advanced Bionutrition

ATR Thrive logo

ATR Thrive

atrthrive.com

Biomilitus logo

Biomilitus

Veterinary Prime logo

Veterinary Prime

Plasma Nutrition logo

Plasma Nutrition

becomeio.com

Bactana logo

Bactana

bactana.com

Mycoinnovation logo

Mycoinnovation

Nutreco logo

Nutreco

nutreco.com

Innova Nutra logo

Innova Nutra

Native Microbials logo

Native Microbials

NutraLife Biosciences logo

NutraLife Biosciences

Akeso Biomedical logo

Akeso Biomedical

Alga Biosciences logo

Alga Biosciences

alga.bio

Nutrivert - Quick Facts

Who are Nutrivert's competitors?

Companies similar to Nutrivert include Pando Nutrition, NovoNutrients, Advanced Bionutrition and ATR Thrive.

When was Nutrivert founded?

Nutrivert was founded in 2016.

Where is Nutrivert's headquarters located?

Nutrivert's headquarters is located in Atlanta, GA, US.

When was Nutrivert's last funding round?

Nutrivert's most recent funding round was for $1.5M (USD) in March 2023.

How much has Nutrivert raised to-date?

As of Mar 22, 2023, Nutrivert has raised a total of $2.5M (USD).

How many employees does Nutrivert have?

Nutrivert has 6 employees as of Feb 5, 2024.

Nutrivert - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Feed Additives
Tags
  • AgTech
  • Cleantech
  • eCommerce
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
  • 311100Animal Food Manufacturing
  • 311110Animal Food Manufacturing
SIC
  • 2000Food And Kindred Products
  • 2040Grain Mill Products
  • 2048Prepared Feeds And Feed Ingredients For Animals And Fowls, Except Dog And Cat
Show 2 more industry codes
NAICS
  • 110000Agriculture, Forestry, Fishing and Hunting
SIC
  • 200Agricultural Production-livestock And Animal Specialties